Skip to main content
. 2020 Apr 16;12(4):364. doi: 10.3390/pharmaceutics12040364

Figure 8.

Figure 8

In vitro biological activities of GLP1_C, GLP1_16HSA, GLP1_19HSA, and GLP1_28HSA determined in GLP-1R-expressing cells. GLP-1R-expressing HEK cells were treated with increasing concentrations of GLP1_C, GLP1_16HSA, GLP1_19HSA, or GLP1_28HSA. The y-axis values were converted to percentages by averaging the cAMP production of 10−7 M GLP1_C. Each data point represents the mean (n = 3) ± SD.